Study to Evaluate Efficacy and Safety of S303 Treated Red Blood Cells (RBCs)in Subjects With Thalassemia Major Requiring Chronic RBC Transfusion

NCT01740531 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Thalassemia Major

Interventions

BIOLOGICAL: S-303 Treated Red Blood Cells (RBCs)
BIOLOGICAL: Conventional, untreated Red Blood Cells

Sponsor

Cerus Corporation